Global Romosozumab Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Romosozumab Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Romosozumab Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 25 mg/vial
  • 1.2.3 75 mg/vial
• 1.3 Market by Application
  • 1.3.1 Global Romosozumab Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Beta-thalassemia
  • 1.3.3 MDS-RS
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Romosozumab Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global Romosozumab Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Romosozumab Revenue by Region (2020-2031)
  • 2.2.3 Global Romosozumab Revenue Market Share by Region (2020-2031)
• 2.3 Global Romosozumab Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global Romosozumab Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Romosozumab Sales by Region (2020-2031)
  • 2.4.3 Global Romosozumab Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global Romosozumab Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Romosozumab Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Romosozumab in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global Romosozumab Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Romosozumab Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 10 and Top 5 Companies by Romosozumab Revenue in 2024
• 3.3 Global Key Players of Romosozumab, Industry Ranking, 2023 VS 2024
• 3.4 Global Romosozumab Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Romosozumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Romosozumab, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Romosozumab, Product Offered and Application
• 3.8 Global Key Manufacturers of Romosozumab, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Sales by Type
  • 4.1.1 Global Romosozumab Historical Sales by Type (2020-2025)
  • 4.1.2 Global Romosozumab Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Romosozumab Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global Romosozumab Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Romosozumab Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Romosozumab Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global Romosozumab Price by Type (2020-2025)
  • 4.3.2 Global Romosozumab Price Forecast by Type (2026-2031)

5 Market Size by Application

• 5.1 Global Sales by Application
  • 5.1.1 Global Romosozumab Historical Sales by Application (2020-2025)
  • 5.1.2 Global Romosozumab Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Romosozumab Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global Romosozumab Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Romosozumab Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Romosozumab Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global Romosozumab Price by Application (2020-2025)
  • 5.3.2 Global Romosozumab Price Forecast by Application (2026-2031)

6 US & Canada

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada Romosozumab Sales by Type (2020-2031)
  • 6.1.2 US & Canada Romosozumab Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada Romosozumab Sales by Application (2020-2031)
  • 6.2.2 US & Canada Romosozumab Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada Romosozumab Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada Romosozumab Revenue by Country (2020-2031)
  • 6.3.3 US & Canada Romosozumab Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe Romosozumab Sales by Type (2020-2031)
  • 7.1.2 Europe Romosozumab Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe Romosozumab Sales by Application (2020-2031)
  • 7.2.2 Europe Romosozumab Revenue by Application (2020-2031)
• 7.3 Europe Market Size by Country
  • 7.3.1 Europe Romosozumab Revenue by Country: 2020 VS 2024 VS 2031
  • 7.3.2 Europe Romosozumab Sales by Country (2020-2031)
  • 7.3.3 Europe Romosozumab Revenue by Country (2020-2031)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Market Size by Type
  • 8.1.1 China Romosozumab Sales by Type (2020-2031)
  • 8.1.2 China Romosozumab Revenue by Type (2020-2031)
• 8.2 China Market Size by Application
  • 8.2.1 China Romosozumab Sales by Application (2020-2031)
  • 8.2.2 China Romosozumab Revenue by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Market Size by Type
  • 9.1.1 Asia Romosozumab Sales by Type (2020-2031)
  • 9.1.2 Asia Romosozumab Revenue by Type (2020-2031)
• 9.2 Asia Market Size by Application
  • 9.2.1 Asia Romosozumab Sales by Application (2020-2031)
  • 9.2.2 Asia Romosozumab Revenue by Application (2020-2031)
• 9.3 Asia Market Size by Region
  • 9.3.1 Asia Romosozumab Revenue by Region: 2020 VS 2024 VS 2031
  • 9.3.2 Asia Romosozumab Revenue by Region (2020-2031)
  • 9.3.3 Asia Romosozumab Sales by Region (2020-2031)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Romosozumab Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America Romosozumab Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Romosozumab Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America Romosozumab Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Romosozumab Revenue by Country: 2020 VS 2024 VS 2031
  • 10.3.2 Middle East, Africa and Latin America Romosozumab Revenue by Country (2020-2031)
  • 10.3.3 Middle East, Africa and Latin America Romosozumab Sales by Country (2020-2031)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Bristol-Myers Squibb
  • 11.1.1 Bristol-Myers Squibb Company Information
  • 11.1.2 Bristol-Myers Squibb Overview
  • 11.1.3 Bristol-Myers Squibb Romosozumab Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 Bristol-Myers Squibb Romosozumab Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Bristol-Myers Squibb Recent Developments
• 11.2 Thermo Fisher Scientific
  • 11.2.1 Thermo Fisher Scientific Company Information
  • 11.2.2 Thermo Fisher Scientific Overview
  • 11.2.3 Thermo Fisher Scientific Romosozumab Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 Thermo Fisher Scientific Romosozumab Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Thermo Fisher Scientific Recent Developments
• 11.3 Celgene
  • 11.3.1 Celgene Company Information
  • 11.3.2 Celgene Overview
  • 11.3.3 Celgene Romosozumab Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 Celgene Romosozumab Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Celgene Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Romosozumab Industry Chain Analysis
• 12.2 Romosozumab Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Romosozumab Production Mode & Process
• 12.4 Romosozumab Sales and Marketing
  • 12.4.1 Romosozumab Sales Channels
  • 12.4.2 Romosozumab Distributors
• 12.5 Romosozumab Customers

13 Romosozumab Market Dynamics

• 13.1 Romosozumab Industry Trends
• 13.2 Romosozumab Market Drivers
• 13.3 Romosozumab Market Challenges
• 13.4 Romosozumab Market Restraints

14 Key Findings in the Global Romosozumab Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Romosozumab Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of 25 mg/vial

Table 3. Major Manufacturers of 75 mg/vial

Table 4. Global Romosozumab Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 5. Global Romosozumab Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 6. Global Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Revenue Market Share by Region (2020-2031)

Table 8. Global Romosozumab Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 9. Global Romosozumab Sales by Region (2020-2031) & (K Units)

Table 10. Global Sales Market Share by Region (2020-2031)

Table 11. Global Romosozumab Sales by Manufacturers (2020-2025) & (K Units)

Table 12. Global Romosozumab Sales Share by Manufacturers (2020-2025)

Table 13. Global Romosozumab Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 14. Global Romosozumab Revenue Market Share by Manufacturers (2020-2025)

Table 15. Global Key Players of Romosozumab, Industry Ranking, 2023 VS 2024 VS 2024

Table 16. Romosozumab Price by Manufacturers (2020-2025) & (US$/Unit)

Table 17. Global Romosozumab Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 18. Global Romosozumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Romosozumab as of 2024)

Table 19. Global Key Manufacturers of Romosozumab, Manufacturing Base Distribution and Headquarters

Table 20. Global Key Manufacturers of Romosozumab, Product Offered and Application

Table 21. Global Key Manufacturers of Romosozumab, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Romosozumab Sales by Type (2020-2025) & (K Units)

Table 24. Global Romosozumab Sales by Type (2026-2031) & (K Units)

Table 25. Global Sales Share by Type (2020-2031)

Table 26. Global Romosozumab Revenue by Type (2020-2025) & (US$ Million)

Table 27. Global Romosozumab Revenue by Type (2026-2031) & (US$ Million)

Table 28. Global Revenue Share by Type (2020-2031)

Table 29. Romosozumab Price by Type (2020-2025) & (US$/Unit)

Table 30. Global Romosozumab Price Forecast by Type (2026-2031) & (US$/Unit)

Table 31. Global Romosozumab Sales by Application (2020-2025) & (K Units)

Table 32. Global Romosozumab Sales by Application (2026-2031) & (K Units)

Table 33. Global Sales Share by Application (2020-2031)

Table 34. Global Romosozumab Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Romosozumab Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Revenue Share by Application (2020-2031)

Table 37. Romosozumab Price by Application (2020-2025) & (US$/Unit)

Table 38. Global Romosozumab Price Forecast by Application (2026-2031) & (US$/Unit)

Table 39. US & Canada Sales by Type (2020-2031) & (K Units)

Table 40. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 41. US & Canada Sales by Application (2020-2031) & (K Units)

Table 42. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 43. US & Canada Romosozumab Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 45. US & Canada Sales by Country (2020-2031) & (K Units)

Table 46. Europe Sales by Type (2020-2031) & (K Units)

Table 47. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 48. Europe Sales by Application (2020-2031) & (K Units)

Table 49. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 50. Europe Romosozumab Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 51. Europe Sales by Country (2020-2031) & (K Units)

Table 52. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 53. China Sales by Type (2020-2031) & (K Units)

Table 54. China Revenue by Type (2020-2031) & (US$ Million)

Table 55. China Sales by Application (2020-2031) & (K Units)

Table 56. China Revenue by Application (2020-2031) & (US$ Million)

Table 57. Asia Sales by Type (2020-2031) & (K Units)

Table 58. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 59. Asia Sales by Application (2020-2031) & (K Units)

Table 60. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 61. Asia Romosozumab Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 62. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 63. Asia Sales by Region (2020-2031) & (K Units)

Table 64. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Units)

Table 65. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 66. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)

Table 67. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 68. Middle East, Africa and Latin America Romosozumab Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 69. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 70. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)

Table 71. Bristol-Myers Squibb Company Information

Table 72. Bristol-Myers Squibb Description and Major Businesses

Table 73. Bristol-Myers Squibb Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 74. Bristol-Myers Squibb Product Model Numbers, Pictures, Descriptions and Specifications

Table 75. Bristol-Myers Squibb Recent Developments

Table 76. Thermo Fisher Scientific Company Information

Table 77. Thermo Fisher Scientific Description and Major Businesses

Table 78. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 79. Thermo Fisher Scientific Product Model Numbers, Pictures, Descriptions and Specifications

Table 80. Thermo Fisher Scientific Recent Developments

Table 81. Celgene Company Information

Table 82. Celgene Description and Major Businesses

Table 83. Celgene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 84. Celgene Product Model Numbers, Pictures, Descriptions and Specifications

Table 85. Celgene Recent Developments

Table 86. Key Raw Materials Lists

Table 87. Raw Materials Key Suppliers Lists

Table 88. Distributors List

Table 89. Customers List

Table 90. Market Trends

Table 91. Market Drivers

Table 92. Market Challenges

Table 93. Market Restraints

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

List of Figures

Figure 1. Romosozumab Product Picture

Figure 2. Global Romosozumab Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Romosozumab Market Share by Type: 2024 & 2031

Figure 4. 25 mg/vial Product Picture

Figure 5. 75 mg/vial Product Picture

Figure 6. Global Romosozumab Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Romosozumab Market Share by Application: 2024 & 2031

Figure 8. Beta-thalassemia

Figure 9. MDS-RS

Figure 10. Romosozumab Report Years Considered

Figure 11. Global Romosozumab Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 13. Global Romosozumab Revenue by Region (2020-2031) (US$ Million)

Figure 14. Global Romosozumab Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 15. Global Romosozumab Revenue Market Share by Region (2020-2031)

Figure 16. Global Romosozumab Sales (2020-2031) & (K Units)

Figure 17. Global Romosozumab Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 18. Global Romosozumab Sales Market Share by Region (2020-2031)

Figure 19. US & Canada Romosozumab Sales YoY (2020-2031) & (K Units)

Figure 20. US & Canada Romosozumab Revenue YoY (2020-2031) & (US$ Million)

Figure 21. Europe Romosozumab Sales YoY (2020-2031) & (K Units)

Figure 22. Europe Romosozumab Revenue YoY (2020-2031) & (US$ Million)

Figure 23. China Romosozumab Sales YoY (2020-2031) & (K Units)

Figure 24. China Romosozumab Revenue YoY (2020-2031) & (US$ Million)

Figure 25. Asia (excluding China) Romosozumab Sales YoY (2020-2031) & (K Units)

Figure 26. Asia (excluding China) Romosozumab Revenue YoY (2020-2031) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Romosozumab Sales YoY (2020-2031) & (K Units)

Figure 28. Middle East, Africa and Latin America Romosozumab Revenue YoY (2020-2031) & (US$ Million)

Figure 29. Global Romosozumab Sales Share by Manufacturers (2024)

Figure 30. The Romosozumab Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 31. Global Romosozumab Revenue Share by Manufacturers (2024)

Figure 32. The Top 5 and 10 Largest Manufacturers of Romosozumab in the World: Market Share by Romosozumab Revenue in 2024

Figure 33. Global Romosozumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 34. Global Romosozumab Sales Market Share by Type (2020-2031)

Figure 35. Global Romosozumab Revenue Market Share by Type (2020-2031)

Figure 36. Global Romosozumab Sales Market Share by Application (2020-2031)

Figure 37. Global Romosozumab Revenue Market Share by Application (2020-2031)

Figure 38. US & Canada Romosozumab Sales Market Share by Type (2020-2031)

Figure 39. US & Canada Romosozumab Revenue Market Share by Type (2020-2031)

Figure 40. US & Canada Romosozumab Sales Market Share by Application (2020-2031)

Figure 41. US & Canada Romosozumab Revenue Market Share by Application (2020-2031)

Figure 42. US & Canada Romosozumab Revenue Share by Country (2020-2031)

Figure 43. US & Canada Romosozumab Sales Share by Country (2020-2031)

Figure 44. US Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 45. Canada Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 46. Europe Romosozumab Sales Market Share by Type (2020-2031)

Figure 47. Europe Romosozumab Revenue Market Share by Type (2020-2031)

Figure 48. Europe Romosozumab Sales Market Share by Application (2020-2031)

Figure 49. Europe Romosozumab Revenue Market Share by Application (2020-2031)

Figure 50. Europe Romosozumab Sales Share by Country (2020-2031)

Figure 51. Europe Romosozumab Revenue Share by Country (2020-2031)

Figure 52. Germany Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 53. France Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 54. U.K. Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 55. Italy Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 56. Russia Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 57. China Romosozumab Sales Market Share by Type (2020-2031)

Figure 58. China Romosozumab Revenue Market Share by Type (2020-2031)

Figure 59. China Romosozumab Sales Market Share by Application (2020-2031)

Figure 60. China Romosozumab Revenue Market Share by Application (2020-2031)

Figure 61. Asia Romosozumab Sales Market Share by Type (2020-2031)

Figure 62. Asia Romosozumab Revenue Market Share by Type (2020-2031)

Figure 63. Asia Romosozumab Sales Market Share by Application (2020-2031)

Figure 64. Asia Romosozumab Revenue Market Share by Application (2020-2031)

Figure 65. Asia Romosozumab Revenue Share by Region (2020-2031)

Figure 66. Asia Romosozumab Sales Share by Region (2020-2031)

Figure 67. Japan Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 68. South Korea Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 69. China Taiwan Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 70. Southeast Asia Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 71. India Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 72. Australia Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 73. Middle East, Africa and Latin America Romosozumab Sales Market Share by Type (2020-2031)

Figure 74. Middle East, Africa and Latin America Romosozumab Revenue Market Share by Type (2020-2031)

Figure 75. Middle East, Africa and Latin America Romosozumab Sales Market Share by Application (2020-2031)

Figure 76. Middle East, Africa and Latin America Romosozumab Revenue Market Share by Application (2020-2031)

Figure 77. Middle East, Africa and Latin America Romosozumab Revenue Share by Country (2020-2031)

Figure 78. Middle East, Africa and Latin America Romosozumab Sales Share by Country (2020-2031)

Figure 79. Brazil Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 80. Mexico Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 81. Turkey Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 82. Israel Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 83. GCC Countries Romosozumab Revenue (2020-2031) & (US$ Million)

Figure 84. Value Chain

Figure 85. Romosozumab Production Process

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed